Treatment potential in Lymphomas

Effectivness of ASP3026 (which is no longer in clinical trials for this disease) was tested on NPM-ALK in lymphomas with positive results.

http://impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=2170&path%5B%5D=3439

This entry was posted in Anaplastic Large-Cell Lymphomas, ASP3026 from Astellas, Potential Treatments, Research. Bookmark the permalink.

Leave a Reply